Displaying items by tag: department of neurology

Deep brain stimulation has long been used to treat Parkinson’s disease, and was approved for use in epilepsy late in 2018.
Kazamel’s duties will include planning more than 45 workshops on topics ranging from electromyography to neuromuscular ultrasound.
Lauched in partnership with The Michael J. Fox Foundation for Parkinson’s Research in 2014, the program provides resources for top centers to train new clinician-researcher movement disorder specialists.
The Junior Board of Alzheimer’s of Central Alabama will fund a UAB program to train the next generation of Alzheimer’s disease researchers.
A new screening tool developed at UAB has been shown to be an effective aid in determining the severity of cognitive issues.
The FDA's approval of Epiliodex could open the door for increased research of cannabis-based therapies, says UAB researcher.
More than a third of people have the biology of Alzheimer’s disease but not the symptoms. Understanding why could lead to new therapies.
The Blazer Bolt for Brain Cancer boasts record attendance as it raises money for brain tumor research
UAB investigators are looking at the intriguing possibility of a connection between the gut microbiome and Parkinson’s disease.
Researchers will delve into the role of inflammation and the immune system in the worsening of Parkinson’s disease as UAB is named a Udall Center of Excellence.
UAB was part of a national, multisite study that showed a drug for multiple sclerosis was effective in slowing down brain atrophy, or shrinkage.
The goal is an early warning system to block incipient seizures for patients where medications have failed.
UAB research suggests protein misfolding, perhaps caused by a reduction in a regulatory protein, could be associated with Parkinson’s disease.
UAB's study of CBD oil for intractable epilepsy, funded by the State of Alabama under Carly's Law, shows that CBD oil reduces seizure frequency and severity in patients with treatment-resistant epilepsy.
Page 4 of 12